BILL ANALYSIS

HR1903

NEUTRAL

Congressional Trade Authority Act of 2025

HR1903 (Congressional Trade Authority Act of 2025) has been assessed with a neutral outlook for investors. The primary sectors impacted are Defense, Energy and Infrastructure. View the full bill text on Congress.gov.

neutral

Market Sentiment

2/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR1903 has been dormant for 13 months — no floor action, no hearings, no markups

Zero funding authorized; this changes who decides tariffs, not how much is spent

Defense and energy stocks are moving on other factors (budget uncertainty, not this bill)

Only 20 cosponsors, all junior — no evidence of leadership support for advancement

How HR1903 Affects the Market

No market implications exist for this bill in its current state. The 13-month legislative dormancy since referral in March 2025 indicates no near-term path to passage. Defense primes like $LMT ($510.63) and $NOC ($577.22) are reacting to broader budget and geopolitical factors, not this procedural tariff bill. $NEE ($96.04) is near its 52-week high on utility sector strength, entirely unrelated.

Bill Details

Metric	Value
Bill Number	HR1903
Market Sentiment	neutral
Event Date	March 6, 2025
Affected Sectors	Defense, Energy, Infrastructure
Source	View on Congress.gov →

Summary

HR1903 is a procedural bill introduced 13 months ago with zero floor action. It would transfer tariff authority from the President to Congress but has no funding, no scheduled vote, and no market impact in its current state. No ticker warrants a causal chain.

Full AI Market Analysis

This is an early-stage authorization bill (HR1903) that would amend Section 232 of the Trade Expansion Act of 1962 to require congressional approval for presidential import adjustments tied to national security. The bill limits such adjustments to goods essential for military equipment, energy resources, or critical infrastructure. It has been referred to two committees (Ways and Means, Rules) since March 2025 with no further action in 13 months. There is zero funding authorized or appropriated — the bill is purely procedural, changing the decision-making process for future tariffs without allocating any money. No companies are directly named or affected by this legislation at this stage. The 20 cosponsors are all junior members; no committee chairs are sponsoring. Real market data shows defense stocks $LMT (-15.51% 30-day) and $NOC (-15.39% 30-day) are under significant selling pressure unrelated to this dormant bill. $NEE (+3.4% 30-day) shows no correlation. Until the bill advances from committee to floor consideration, it has zero market relevance.